drugset / Trial / NCT01568034
A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to investigate the effect of BIA 9-1067 on the levodopa pharmacokinetics when administered in combination with immediate release levodopa/carbidopa or levodopa/benserazide in Parkinson's Disease (PD) patients.
Timeline
- Start
- 2009-04
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Opicapone | Small molecule | 25 mg | — |
| Subject | Opicapone | Small molecule | 50 mg | — |
| Subject | Opicapone | Small molecule | 100 mg | — |
| Background | Benzerazide | Unknown | 25 mg | — |
| Background | Carbidopa | Unknown | 25 mg | — |
| Background | Levodopa | Unknown | 100 mg | — |